21 results on '"Markulev, Connie"'
Search Results
2. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
3. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people
4. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis
5. Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study
6. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial
7. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis
8. Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial
9. Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning
10. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial
11. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youth at Ultra-High Risk for Psychosis
12. Clinical trajectories in the ultra-high risk for psychosis population
13. Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis
14. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis
15. The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controls
16. The relationship between stress, HPA axis functioning and brain structure in first episode psychosis over the first 12 weeks of treatment
17. Poster #M62 WHITE MATTER VOLUME REDUCTIONS IN FIRST EPISODE PSYCHOSIS ARE ASSOCIATED WITH CORTISOL LEVELS
18. Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis
19. The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study
20. The topical niacin sensitivity test: An inter- and intra-rater reliability study in healthy controls
21. GLUCOCORTICOID SENSITIVITY IN MONONUCLEAR LEUKOCYTES IN FIRST EPISODE PSYCHOSIS PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.